跳至主要内容
临床试验/NCT05279612
NCT05279612进行中(未招募)不适用

Effect Analysis of Neoadjuvant Chemoradiotherapy Combined With Radical Surgery ( CME + D3 ) for Advanced Colon Cancer : Prospective, a Single-arm, Single Central, Clinical Trial Research

Tang-Du Hospital1 个研究点 分布在 1 个国家目标入组 177 人开始时间: 2021年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
177
试验地点
1
主要终点
Investigate patients ORR

研究概览

简要总结

In this study, a randomized controlled trial was conducted on advanced colon cancer patients with preoperative tumor staging T1-4/N1-2/M0 or T4/N0/M0 to determine the effectiveness of preoperative short-term radiotherapy combined with chemotherapy and whether it can effectively reduce the postoperative local recurrence rate, so as to provide better treatment for colon cancer patients and improve the oncological treatment effect of colon cancer.

详细描述

This is prospective,a single-arm, single center, clinical trail study.The patient entered the study after meeting that criteria.The ORR, R0 resection, OS and DFS of patients and neoplasm down-staging status,etc would be compared.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of colon neoplasm
  • 18 years to 70 years
  • Preoperative abdominal enhanced CT or MRI showed cT4, cN0-2
  • ECOGS score≤2
  • thoraco-abdomina CT showed no obvious metastasis(The CT of liver and lung show uncertainty tubercle,suggestive performed PET-CT) cT4,cN0-2,M0 radiography Inclusion Criteria(according postoperative enhanced CT or MRI)
  • progress tubercle penetrate peritoneotome base
  • progress tubercle penetrate serous surface of neighboring organ
  • progress tubercle development by late mesentery or side abdominis

排除标准

  • Appeared other system cancer
  • Patient with postoperative recurrent of colon cancer
  • Patient with malignancies history in recent 5 years
  • Pregnant or female of suckle period
  • The patient have adjuvant radiotherapy record in other system cancer before this time treatment,and Patient with surgical contraindications.
  • The patient have accepted adjuvant chemoradiotherapy before this time treatment.
  • Distant metastasis found during surgery
  • Patients with poor radiotherapy compliance and difficulty in coordination
  • Patients with mental disorders

结局指标

主要结局

Investigate patients ORR

时间窗: 7 days after surgery

Investigate patients ORR(objective response rate ) include CR(complete response) and PR(partial response)

次要结局

  • neoplasm down-staging status(one month after surgery)
  • R0 resection(immediately after surgery)
  • Quality of life score(one month after surgery)
  • Investigate operation safety score(one month after surgery)
  • local recurrent rate of neoplasm(2 years after surgery)
  • Investigate patience pRR (pathologic response rate)(7 days after surgery)

研究者

发起方
Tang-Du Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验